|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$21,926,350 |
|
|
Indirect Value
|
$61,758 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$21,988,108 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-06-29 |
4 |
OE |
$86.52 |
$330,578 |
D/D |
3,708 |
50,460 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-11-04 |
4 |
OE |
$86.52 |
$330,578 |
D/D |
3,708 |
34,793 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-03 |
4 |
OE |
$86.52 |
$330,756 |
D/D |
3,710 |
36,950 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-03 |
4 |
AS |
$211.22 |
$332,146 |
D/D |
(1,554) |
69,957 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-02-13 |
4 |
AS |
$88.39 |
$335,175 |
D/D |
(3,792) |
127,455 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-16 |
4 |
AS |
$158.28 |
$336,345 |
D/D |
(2,125) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-04-16 |
4 |
AS |
$163.01 |
$346,396 |
D/D |
(2,125) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-05-02 |
4 |
AS |
$168.56 |
$364,768 |
D/D |
(2,155) |
33,240 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-02 |
4 |
AS |
$169.42 |
$365,270 |
D/D |
(2,156) |
41,952 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-11-07 |
4 |
AS |
$179.00 |
$380,375 |
D/D |
(2,125) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-07-16 |
4 |
AS |
$179.85 |
$382,181 |
D/D |
(2,125) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-08-02 |
4 |
AS |
$177.78 |
$383,116 |
D/D |
(2,155) |
32,240 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-06-19 |
4 |
AS |
$181.89 |
$386,516 |
D/D |
(2,125) |
33,240 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-08-08 |
4 |
AS |
$181.89 |
$386,516 |
D/D |
(2,125) |
33,240 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-05-04 |
4 |
AS |
$259.36 |
$404,957 |
D/D |
(1,553) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-01-22 |
4 |
AS |
$193.48 |
$411,145 |
D/D |
(2,125) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-08-03 |
4 |
AS |
$276.40 |
$432,337 |
D/D |
(1,553) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-03 |
4 |
OE |
$109.14 |
$463,845 |
D/D |
4,250 |
125,367 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-01-11 |
4 |
OE |
$109.14 |
$463,845 |
D/D |
4,250 |
46,202 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-06-22 |
4 |
OE |
$109.14 |
$463,845 |
D/D |
4,250 |
51,002 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-08-02 |
4 |
OE |
$91.05 |
$476,479 |
D/D |
4,280 |
48,907 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2014-11-05 |
4 |
AS |
$112.07 |
$478,121 |
D/D |
(4,250) |
117,264 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-07-07 |
4 |
OE |
$155.57 |
$483,403 |
D/D |
2,786 |
37,965 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-06 |
4 |
OE |
$155.57 |
$483,559 |
D/D |
2,787 |
70,350 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-09-04 |
4 |
OE |
$53.74 |
$487,046 |
D/D |
9,063 |
136,578 |
0 |
- |
|
192 Records found
|
|
Page 4 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|